Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-01 | 2024-03 | -0.04 | N/A | N/A | N/A |
2024-02-29 | 2023-12 | -0.04 | N/A | N/A | N/A |
2023-11-01 | 2023-09 | -0.02 | N/A | N/A | N/A |
2023-08-02 | 2023-06 | -0.02 | 0.02 | 0.04 | 200.00% |
2023-05-03 | 2023-03 | -0.01 | 0.02 | 0.03 | 300.00% |
2023-03-01 | 2022-12 | 0.01 | 0.02 | 0.01 | 100.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-07-19 | Goldman Sachs | Upgrade | Sell | Sell |
2023-07-18 | Northland Capital Markets | Upgrade | Market Perform | Market Perform |
2023-01-05 | Jefferies | Upgrade | Hold | Buy |
2022-10-18 | SVB Leerink | Upgrade | Market Perform | |
2022-05-23 | Goldman Sachs | Upgrade | Sell | |
2022-05-05 | JP Morgan | Downgrade | Neutral | Underweight |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-30 | BERG AARON D. | Officer | 633.26K | Conversion of Exercise of derivative security |
2024-01-21 | HOLT PATRICK | Chief Executive Officer | 314.43K | Purchase |
2022-07-28 | KALB MICHAEL WAYNE | Chief Financial Officer | 337.31K | Conversion of Exercise of derivative security |
2024-01-30 | KETCHUM STEVEN B | Officer | 658.72K | Conversion of Exercise of derivative security |
2022-08-18 | MARKS JASON M | Officer | 21.92K | Conversion of Exercise of derivative security |
2023-02-20 | MIKHAIL KARIM | Chief Executive Officer | 283.51K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Kynam Capital Management, LP | 12.00M | 14.28M | 12.15% |
2023-06-29 | Morgan Stanley | 11.28M | 13.42M | 11.41% |
2023-06-29 | Eversept Partners, LP | 10.50M | 12.50M | 10.63% |
2023-06-29 | Tang Capital Management, LLC | 7.10M | 8.45M | 7.19% |
2023-06-29 | SCP Investment, LP | 6.50M | 7.74M | 6.58% |
2023-06-29 | DG Capital Management, LLC | 5.47M | 6.51M | 5.54% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Northern Lights Fd Tr-13D Activist Fd | 3.81M | 4.53M | 3.85% |
2023-06-29 | Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund | 585.00K | 696.15K | 0.59% |
2023-06-29 | Legg Mason Clearbridge Small Cap Value Fd | 531.07K | 631.97K | 0.54% |
2023-06-29 | Columbia Fds Var Ser Tr II-Columbia Var Port-Overseas Core Fd | 458.93K | 546.12K | 0.46% |
2023-05-30 | Columbia Fds Ser Tr-Columbia Overseas Value Fd | 315.88K | 369.58K | 0.32% |
2023-05-30 | Fidelity NASDAQ Composite Index Fund | 214.39K | 250.83K | 0.22% |
Split | Date |
---|---|
0.1 : 1 | 2008-01-18 |
0.1 : 1 | 1998-10-19 |
-
Jordan’s yacht
-
Hey Mr Pipe Dream....how is that ode dive treating you now?
-
Shorts and longs know this is going up in September. When you see a drop.......buy, buy, buy!!!!
-
Fellow longs - all the Amarin trends are “sell the news”. Does this continue until label expansion? Manipulation at its best
-
Konstantinos is an idiot! MEMORIAL DAY IS A HOLIDAY IN THE US! 4 day work week moron!
-
Jordan, JT Pipe Dream and all other shorts.....any opinions on this article?
https://alphastocknews.com/amarin-amrn-stock-is-dipping-grab-the-discount/245/
-
I think Jordan is actually Frank Jr.
-
The typical target price seems to be the $51pps. Why would anyone think differently?
-
-
This could get really ugly tomorrow
-
Vescepa could cure cancer, diabetes and heart disease....but it won’t matter for PPS if a trade agreement is never reached - Morgan Stanley certainly thinks we could be in trouble
-
Gee - look what Seeking Alpha said - label expansion expected.
-
Amen James - well said
-
Can I ask an honest question of shorts like JT Pipe Dream and Jordan? Do you really think your depressing, crappy posts actually influence people to give up and sell? You both seem like intelligent, logical people who know the Seeking Alpha article is junk and was only released in response to the Priority Review as a last ditch effort to save shorts.
-
Obvious the Seeking Alpha BS article was written in response to the Priority Review approval to try and save the shorts. The stock is not going anywhere until BO. Shorts know it. Between $16.50 and $19.50 until BO.
-
Going to pull all my money out of the market. Amarin could cure heart disease, cancer and diabetes and this stock will still lose due to tariffs. Timing is everything and the timing of Amarin growth will be futile as market crashes.
-
-
MM’s will keep this between $16.50 and $19.50 until BO.
-
The best news in roughly 8 months and this stock can barely hold a $2.00 increase? Wow....BO should net us another $3pps
-
For people saying no buyout - how do you know what’s in the works? Are you the same bears who said no priority review? Please just stop posting with no backup.
-
Amarin Corporation plc (AMRN) Q4 2023 Earnings Call Transcript
seekingalpha.com • -
Amarin: Sarissa Is Giving Me Hope Again
seekingalpha.com • -
Why Amarin Stock Skyrocketed Today
fool.com • -
Amarin stock soars on preliminary 4Q revenue guidance, share buyback plan
proactiveinvestors.com • -
Amarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
What Makes Amarin (AMRN) a New Buy Stock
zacks.com • -
Soleno Therapeutics: Impressive Data, But Never Forget Amarin
seekingalpha.com • -
Amarin to Present at the 2023 Cantor Global Healthcare Conference
globenewswire.com • -
10 Top Penny Stocks To Buy According To Insiders In August
pennystocks.com • -
Amarin: New Management, But No Radical Changes To Strategy, Or Outlook
seekingalpha.com • -
Amarin to Present at Two Upcoming Investor Conferences
globenewswire.com • -
Amarin: Sarissa Has Control, But Amarin Will Need Patience
seekingalpha.com • -
Penny Stocks To Buy: 5 To Watch Before Next Week
pennystocks.com • -
Amarin Corporation plc (AMRN) Q4 2022 Earnings Call Transcript
seekingalpha.com • -
Positive Events Are Lining Up At Amarin
seekingalpha.com • -
Amarin to Present at Cowen's 43rd Annual Health Care Conference
globenewswire.com • -
Amarin Shareholders Invited to Webcast with Board and Management Team
globenewswire.com • -
Amarin to Present at SVB Securities Global Biopharma Conference
globenewswire.com • -
Why Amarin Stock Tumbled This Week
fool.com • -
3 Penny Stocks to Sell in January Before They Peter Out
investorplace.com • -
Amarin's stock is up 17% on strong revenue estimates for 2022
marketwatch.com • -
Penny Stocks To Buy In 2023? 3 To Watch In January
pennystocks.com • -
Amarin to Present at the 41st Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
Why Amarin (AMRN) Stock Might be a Great Pick
zacks.com • -
Why Amarin Stock Was a Winner Today
fool.com • -
Amarin to Present at Jefferies London Healthcare Conference
globenewswire.com • -
Amarin Corporation plc (AMRN) Q3 2022 Results - Earnings Call Transcript
seekingalpha.com • -
Amarin to Present at H.C. Wainwright's 24th Annual Global Investment Conference
globenewswire.com • -
Why Amarin Stock Was Plunging This Week
fool.com • -
7 F-Rated Growth Stocks to Sell Before Q4
investorplace.com • -
Are Ocugen or Amarin Good Penny Stocks to Buy?
marketbeat.com • -
For Amarin, Something Wishful This Way Comes
seekingalpha.com • -
Does Amarin Deserve a Spot in Your Portfolio after Earnings?
marketbeat.com • -
4 Best Penny Stocks To Buy On Reddit According To Options Traders
pennystocks.com • -
Why Amarin Stock Dipped This Week
fool.com • -
July Penny Stocks Buying Guide, 3 Things to Know
pennystocks.com • -
Why Amarin Stock Is Sinking Today
fool.com • -
Penny Stocks To Buy Now? 4 To Watch With Big News
pennystocks.com • -
Why Amarin Stock Blasted Higher on Friday
fool.com • -
4 Hot Penny Stocks With News To Watch Right Now
pennystocks.com • -
New Strong Sell Stocks for May 13th
zacks.com • -
Why Amarin Shares Are Plunging After Q1 Earnings
benzinga.com • -
Amarin Corp.: Hitting The Thesis Reset Button
seekingalpha.com • -
Amarin: Alex Denner, Health Net, Statin Combo, And Signs Of Better Times
seekingalpha.com • -
3 Penny Stocks to Add to Your Watchlist This Week
pennystocks.com • -
Should These Penny Stocks Be On Your February Watchlist?
pennystocks.com • -
These Hot Penny Stocks Are Climbing While the Stock Market is Down
pennystocks.com • -
Amarin to Present at the 40th Annual J.P. Morgan Healthcare Conference
globenewswire.com • -
Are These Penny Stocks Worth Buying Right Now Or Not?
pennystocks.com • -
Amarin Stock: Sales From China And Europe May Make The Price Spike Up
seekingalpha.com • -
Here's 3 Penny Stocks You Need to Know About Today
pennystocks.com •